Healthtech Startup MedTel raises $500K in Pre-Series A funding Round
Healthtech startup, MedTel Healthcare has raised $500K in its Pre-Series A funding led by undisclosed investors from the US, India, and Australia. Incubated at KIIT - TBI, Bhubaneswar, the startup had earlier raised seed funding from INVENT, Startup Odisha, and Bharat Petroleum Corporation Limited in 2018.
Based in Bangalore, MedTel heathcare was founded in 2017, by DrLalitManik, Dr. Timiresh Das, DrSoumyakant Das, Ajit Choudhury, and Siba Prasad Panda. Incubated at KIIT – TBI, the firm specializes in connected care and remote patient monitoring (RPM) solutions.
“MedTel Healthcare plans to lead disease based connected care solutions encompassing chronic health conditions, pregnancy, oncology, and mental health. MedTel’s tech-based approach in providing healthcare is rooted in smart connected care, digital therapeutics, and interoperability of data,” said DrSoumyakant in a statement.
The firm has launched a home isolation health monitoring product, StopCov. The platform is a Remote Patient Monitoring (RPM) and Telemedicine solution that helps to manage patients diagnosed with COVID-19 by tracking vital signs and other symptoms. MedTel’s other patient-centric product is an easy-to-use, patient-centric digital health platform that gives real-time access to care providers, strengthened with predictive analytics.
The firm believes that patients usually miss their routine monitoring for different chronic diseases. The statement said that MedTel’s device-agnostic proprietary platform with evidence-based clinical algorithms reminds patients in every step to adhere to the treatment protocols. “90 percent of consumers believe remote health monitoring devices help better manage chronic conditions. MedTelintends to make hospitals, clinics, individual practitioners, and corporations empowered with its product MedTeli Lab and iRPM,” the statement explained.
MedTel has already served market leaders such as Apex Hospitals, Fortis Healthcare, Apollo Hospitals, Corporates, and has over 30 national and international clients. According to the statement, MedTel intends to utilize the fresh capital towards scaling up, product improvement, disease portfolio expansion, developing wearables, and foray into the health sensors segment.
Based in Bangalore, MedTel heathcare was founded in 2017, by DrLalitManik, Dr. Timiresh Das, DrSoumyakant Das, Ajit Choudhury, and Siba Prasad Panda. Incubated at KIIT – TBI, the firm specializes in connected care and remote patient monitoring (RPM) solutions.
“MedTel Healthcare plans to lead disease based connected care solutions encompassing chronic health conditions, pregnancy, oncology, and mental health. MedTel’s tech-based approach in providing healthcare is rooted in smart connected care, digital therapeutics, and interoperability of data,” said DrSoumyakant in a statement.
The firm has launched a home isolation health monitoring product, StopCov. The platform is a Remote Patient Monitoring (RPM) and Telemedicine solution that helps to manage patients diagnosed with COVID-19 by tracking vital signs and other symptoms. MedTel’s other patient-centric product is an easy-to-use, patient-centric digital health platform that gives real-time access to care providers, strengthened with predictive analytics.
The firm believes that patients usually miss their routine monitoring for different chronic diseases. The statement said that MedTel’s device-agnostic proprietary platform with evidence-based clinical algorithms reminds patients in every step to adhere to the treatment protocols. “90 percent of consumers believe remote health monitoring devices help better manage chronic conditions. MedTelintends to make hospitals, clinics, individual practitioners, and corporations empowered with its product MedTeli Lab and iRPM,” the statement explained.
MedTel has already served market leaders such as Apex Hospitals, Fortis Healthcare, Apollo Hospitals, Corporates, and has over 30 national and international clients. According to the statement, MedTel intends to utilize the fresh capital towards scaling up, product improvement, disease portfolio expansion, developing wearables, and foray into the health sensors segment.
.jpg "Multycomm : Streamlining Enterprise Communications for an Enhanced Customer Experience & Brand Connect")
